Q2 2018 Holdings
Filed 2018-08-14 | 46 holdings | $62.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $20.7M | 210,000 | 33.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.4M | 150,000 | 19.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $11.6M | 175,000 | 18.6% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $9.5M | 700,000 | 15.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $8.2M | 535,000 | 13.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $29.6K | 1,250,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $24.7K | 500,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $23.1K | 175,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $22.8K | 675,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $16.5K | 105,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $10.9K | 242,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $10.7K | 600,000 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $9.2K | 235,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $8.6K | 400,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $8.1K | 660,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $7.6K | 295,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $7.6K | 1,900,000 | 0.0% |
| Endocyte Inc | COM | 29269A102 | $6.9K | 500,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $6.9K | 350,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $6.6K | 23,500 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $6.6K | 230,000 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $6.5K | 400,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $6.2K | 900,000 | 0.0% |
| Obseva SA | COM | H5861P103 | $6.1K | 400,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $5.6K | 186,019 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $4.8K | 125,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $4.6K | 360,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.2K | 230,000 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $4.2K | 1,411,247 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $4.1K | 355,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.1K | 185,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $3.8K | 600,000 | 0.0% |
| Lannet Inc | COM | 516012101 | $3.4K | 250,000 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $3.0K | 3,525,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $2.8K | 450,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $1.1K | 15,700 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $1.0K | 102,263 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $947 | 33,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $828 | 14,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $773 | 750,792 | 0.0% |
| Motus GI Hldgs Inc | COM | 62014P108 | $719 | 100,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $684 | 52,000 | 0.0% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $608 | 29,000 | 0.0% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $525 | 5,000 | 0.0% |
| Lannet IncCall | COM | 516012101 | $520 | 2,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $122 | 2,000 | 0.0% |